Johannes H Voigt

Person

Union, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted quinoxalines as inhibitors of fatty acid binding protein
- Patent number 8,889,683
- Issue date Nov 18, 2014
- Merck Sharp & Dohme Corp.
- Clifford Cheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of fatty acid binding protein (FABP)
- Patent number 8,815,875
- Issue date Aug 26, 2014
- Merck Sharp & Dohme Corp.
- Gerald W. Shipps
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,778,980
- Issue date Jul 15, 2014
- Merck Sharp & Dohme Corp.
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of fatty acid binding protein (FABP)
- Patent number 8,759,357
- Issue date Jun 24, 2014
- Merck Sharp & Dohme Corp.
- Gerald W. Shipps
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic heterocyclic aspartyl protease inhibitors
- Patent number 8,557,798
- Issue date Oct 15, 2013
- Merck Sharp & Dohme Corp.
- Ulrich Iserloh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gamma secretase modulators
- Patent number 8,357,682
- Issue date Jan 22, 2013
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic amine BACE-1 inhibitors having a benzamide substituent
- Patent number 8,278,334
- Issue date Oct 2, 2012
- Merck, Sharp & Dohme Corp.
- Jared N. Cumming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,242,112
- Issue date Aug 14, 2012
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 8,178,513
- Issue date May 15, 2012
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic beta-secretase inhibitors
- Patent number 8,012,953
- Issue date Sep 6, 2011
- Schering Corporation
- Andrew W. Stamford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 7,973,067
- Issue date Jul 5, 2011
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic amine bace-1 inhibitors having a heterocyclic substituent
- Patent number 7,910,590
- Issue date Mar 22, 2011
- Schering Corporation
- Ying Huang
- C04 - CEMENTS CONCRETE ARTIFICIAL STONE CERAMICS REFRACTORIES
Information Patent Grant
Aspartyl protease inhibitors
- Patent number 7,868,000
- Issue date Jan 11, 2011
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic heterocyclic aspartyl protease inhibitors
- Patent number 7,812,013
- Issue date Oct 12, 2010
- Schering Corporation
- Ulrich Iserloh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 7,763,609
- Issue date Jul 27, 2010
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 7,700,603
- Issue date Apr 20, 2010
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic amine BACE-1 inhibitors having a benzamide substituent
- Patent number 7,662,816
- Issue date Feb 16, 2010
- Schering Corporation
- Jared N. Cumming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic β-secretase inhibitors
- Patent number 7,652,003
- Issue date Jan 26, 2010
- Schering-Plough Corporation
- Andrew W Stamford
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic amine BACE-1 inhibitors having a heterocyclic substituent
- Patent number 7,598,250
- Issue date Oct 6, 2009
- Schering Corporation
- Jared N. Cumming
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic aspartyl protease inhibitors
- Patent number 7,592,348
- Issue date Sep 22, 2009
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 d...
- Patent number 7,259,142
- Issue date Aug 21, 2007
- The United States of America, represented by The Secretary, Department of Hea...
- Peter P Roller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
SH2 domain binding inhibitors
- Patent number 6,977,241
- Issue date Dec 20, 2005
- The United States of America as represented by the Department of Health and H...
- Terrence R. Burke, Jr.
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20150105354
- Publication date Apr 16, 2015
- MERCK SHARP & DOHME CORP.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20130018066
- Publication date Jan 17, 2013
- Schering Corporation & Pharmacopeia Drug Discovery Inc.
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20120231017
- Publication date Sep 13, 2012
- Pharmacopeia Inc.
- ZHAONING ZHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20120231018
- Publication date Sep 13, 2012
- Pharmacopeia Inc.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF FATTY ACID BINDING PROTEIN (FABP)
- Publication number 20120190696
- Publication date Jul 26, 2012
- Schering Corporation
- Gerald W. Shipps, JR.
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF FATTY ACID BINDING PROTEIN
- Publication number 20120122837
- Publication date May 17, 2012
- CLIFFORD CHENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF FATTY ACID BINDING PROTEIN (FABP)
- Publication number 20110237575
- Publication date Sep 29, 2011
- Gerald W. Shipps, JR.
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20100292203
- Publication date Nov 18, 2010
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GAMMA SECRETASE MODULATORS
- Publication number 20100247514
- Publication date Sep 30, 2010
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC BETA-SECRETASE INHIBITORS
- Publication number 20100178294
- Publication date Jul 15, 2010
- Schering Corporation
- Andrew W. Stamford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIC AMINE BACE-1 INHIBITORS HAVING A BENZAMIDE SUBSTITUENT
- Publication number 20100152138
- Publication date Jun 17, 2010
- Schering Corp.
- Jared N. Cumming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Macrocyclic Heterocyclic Aspartyl Protease Inhibitors
- Publication number 20100063121
- Publication date Mar 11, 2010
- Schering Corporation
- Ulrich Iserloh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIC AMINE BACE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT
- Publication number 20090312341
- Publication date Dec 17, 2009
- Schering Corporation
- Jared N. Cumming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20090306047
- Publication date Dec 10, 2009
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS
- Publication number 20090258868
- Publication date Oct 15, 2009
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic aspartyl protease inhibitors
- Publication number 20080200445
- Publication date Aug 21, 2008
- Schering Corporation and Pharmacopeia Drug Discovery, Inc.
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REDOX-STABLE, NON-PHOSPHORYLATED CYCLIC PEPTIDE INHIBITORS OF SH2 D...
- Publication number 20080031812
- Publication date Feb 7, 2008
- GOVERNMENT OF THE USA, REPRESENTED BY THE SECRETARY, DEPA.
- Peter P. Roller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocyclic aspartyl protease inhibitors
- Publication number 20070072852
- Publication date Mar 29, 2007
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Aspartyl protease inhibitors
- Publication number 20070060575
- Publication date Mar 15, 2007
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Macrocyclic heterocyclic aspartyl protease inhibitors
- Publication number 20060281729
- Publication date Dec 14, 2006
- Schering Corporation
- Ulrich Iserloh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic aspartyl protease inhibitors
- Publication number 20060111370
- Publication date May 25, 2006
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Macrocyclic beta-secretase inhibitors
- Publication number 20060040948
- Publication date Feb 23, 2006
- Andrew W. Stamford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclic amine bace-1 inhibitors having a benzamide substituent
- Publication number 20050119227
- Publication date Jun 2, 2005
- Schering Corporation
- Jared N. Cumming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclic amine BACE-1 inhibitors having a heterocyclic substituent
- Publication number 20050043290
- Publication date Feb 24, 2005
- Schering Corporation and Pharmacopeia Drug Discovery Inc.
- Jared N. Cumming
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sh2 domain binding inhibitors
- Publication number 20040048788
- Publication date Mar 11, 2004
- Terrence R Burke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Johannes H Voigt

Person

Patents Grantslast 30 patents

Substituted quinoxalines as inhibitors of fatty acid binding protein

Inhibitors of fatty acid binding protein (FABP)

Heterocyclic aspartyl protease inhibitors

Inhibitors of fatty acid binding protein (FABP)

Macrocyclic heterocyclic aspartyl protease inhibitors

Gamma secretase modulators

Cyclic amine BACE-1 inhibitors having a benzamide substituent

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Macrocyclic beta-secretase inhibitors

Heterocyclic aspartyl protease inhibitors

Cyclic amine bace-1 inhibitors having a heterocyclic substituent

Aspartyl protease inhibitors

Macrocyclic heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Cyclic amine BACE-1 inhibitors having a benzamide substituent

Macrocyclic β-secretase inhibitors

Cyclic amine BACE-1 inhibitors having a heterocyclic substituent

Heterocyclic aspartyl protease inhibitors

Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 d...

SH2 domain binding inhibitors

Patents Applicationslast 30 patents

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

INHIBITORS OF FATTY ACID BINDING PROTEIN (FABP)

INHIBITORS OF FATTY ACID BINDING PROTEIN

INHIBITORS OF FATTY ACID BINDING PROTEIN (FABP)

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

GAMMA SECRETASE MODULATORS

MACROCYCLIC BETA-SECRETASE INHIBITORS

CYCLIC AMINE BACE-1 INHIBITORS HAVING A BENZAMIDE SUBSTITUENT

Macrocyclic Heterocyclic Aspartyl Protease Inhibitors

CYCLIC AMINE BACE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS

Heterocyclic aspartyl protease inhibitors

REDOX-STABLE, NON-PHOSPHORYLATED CYCLIC PEPTIDE INHIBITORS OF SH2 D...

Heterocyclic aspartyl protease inhibitors

Aspartyl protease inhibitors

Macrocyclic heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Macrocyclic beta-secretase inhibitors

Cyclic amine bace-1 inhibitors having a benzamide substituent

Cyclic amine BACE-1 inhibitors having a heterocyclic substituent

Sh2 domain binding inhibitors